Long noncoding RNA MIR31HG abrogates the availability of tumor suppressor microRNA-361 for the growth of osteosarcoma

References

• Moore DD, Luu HH. Osteosarcoma. Cancer Treat Res. 2014;162:65–92. doi:10.1007/978-3-319-07323-1_425070231
   PubMedGoogle Scholar
• Anderson ME. Update on survival in osteosarcoma. Orthop Clin North Am. 2016;47(1):283–292. doi:10.1016/j.ocl.2015.08.02226614941
   PubMed Web of Science ®Google Scholar
• Huang X, Zhao J, Bai J, et al. Risk and clinicopathological features of osteosarcoma metastasis to the lung: a population-based study. J Bone Oncol. 2019;16:100230. doi:10.1016/j.jbo.2019.10023030923668
   PubMed Web of Science ®Google Scholar
• Slaby O, Laga R, Sedlacek O. Therapeutic targeting of non-coding RNAs in cancer. Biochem J. 2017;474(24):4219–4251. doi:10.1042/BCJ2017007929242381
   PubMedGoogle Scholar
• Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5–18. doi:10.1038/nrc.2017.9929170536
   PubMed Web of Science ®Google Scholar
• Zheng Y, Liu L, Shukla GC. A comprehensive review of web-based non-coding RNA resources for cancer research. Cancer Lett. 2017;407:1–8. doi:10.1016/j.canlet.2017.08.01528823961
   PubMed Web of Science ®Google Scholar
• Patel JS, Hu M, Sinha G, et al. Non-coding RNA as mediators in microenvironment-breast cancer cell communication. Cancer Lett. 2016;380(1):289–295. doi:10.1016/j.canlet.2015.11.01626582656
   PubMed Web of Science ®Google Scholar
• Kita Y, Yonemori K, Osako Y, et al. Noncoding RNA and colorectal cancer: its epigenetic role. J Hum Genet. 2017;62(1):41–47. doi:10.1038/jhg.2016.6627278790
   PubMed Web of Science ®Google Scholar
• Yang Z, Li X, Yang Y, He Z, Qu X, Zhang Y. Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma. Cell Death Dis. 2016;7(9):e2389. doi:10.1038/cddis.2016.27227685633
   PubMedGoogle Scholar
• Chen R, Wang G, Zheng Y, Hua Y, Cai Z. Long non-coding RNAs in osteosarcoma. Oncotarget. 2017;8(12):20462–20475. doi:10.18632/oncotarget.1472628103585
   PubMedGoogle Scholar
• Huang J, Deng G, Liu T, Chen W, Zhou Y. Long noncoding RNA PCAT-1 acts as an oncogene in osteosarcoma by reducing p21 levels. Biochem Biophys Res Commun. 2018;495(4):2622–2629. doi:10.1016/j.bbrc.2017.12.15729291409
   PubMed Web of Science ®Google Scholar
• Sun Q, Tripathi V, Yoon JH, et al. MIR100 host gene-encoded lncRNAs regulate cell cycle by modulating the interaction between HuR and its target mRNAs. Nucleic Acids Res. 2018;46(19):10405–10416. doi:10.1093/nar/gky69630102375
   PubMed Web of Science ®Google Scholar
• Wang R, Ma Z, Feng L, et al. LncRNA MIR31HG targets HIF1A and P21 to facilitate head and neck cancer cell proliferation and tumorigenesis by promoting cell-cycle progression. Mol Cancer. 2018;17(1):162. doi:10.1186/s12943-018-0916-830458787
   PubMed Web of Science ®Google Scholar
• Qin J, Ning H, Zhou Y, Hu Y, Yang L, Huang R. LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma. Biomed Pharmacother. 2018;99:363–368. doi:10.1016/j.biopha.2018.01.03729367106
   PubMed Web of Science ®Google Scholar
• Montes M, Nielsen MM, Maglieri G, et al. The lncRNA MIR31HG regulates p16(INK4A) expression to modulate senescence. Nat Commun. 2015;6:6967. doi:10.1038/ncomms796725908244
   PubMed Web of Science ®Google Scholar
• Ren ZP, Chu XY, Xue ZQ, et al. Down-regulation of lncRNA MIR31HG correlated with aggressive clinicopathological features and unfavorable prognosis in esophageal squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 2017;21(17):3866–3870.28975978
   PubMed Web of Science ®Google Scholar
• Yan S, Tang Z, Chen K, et al. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression. J Exp Clin Cancer Res. 2018;37(1):214. doi:10.1186/s13046-018-0853-930176933
   PubMedGoogle Scholar
• He A, Chen Z, Mei H, Liu Y. Decreased expression of LncRNA MIR31HG in human bladder cancer. Cancer Biomarker. 2016;17(2):231–236. doi:10.3233/CBM-160635
   PubMed Web of Science ®Google Scholar
• Yang H, Liu P, Zhang J, et al. Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b. Oncogene. 2016;35(28):3647–3657. doi:10.1038/onc.2015.43026549028
   PubMed Web of Science ®Google Scholar
• Wang HW, Lo HH, Chiu YL, et al. Dysregulated miR-361-5p/VEGF axis in the plasma and endothelial progenitor cells of patients with coronary artery disease. PLoS One. 2014;9(5):e98070. doi:10.1371/journal.pone.009807024865854
   PubMed Web of Science ®Google Scholar
• Cui W, Li Y, Xu K, et al. miR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA. Biochem Biophys Res Commun. 2016;479(4):901–906. doi:10.1016/j.bbrc.2016.09.07627641667
   PubMed Web of Science ®Google Scholar
• Gao F, Feng J, Yao H, Li Y, Xi J, Yang J. LncRNA SBF2-AS1 promotes the progression of cervical cancer by regulating miR-361-5p/FOXM1 axis. Artif Cells Nanomed Biotechnol. 2019;47(1):776–782. doi:10.1080/21691401.2019.157788330856345
   PubMed Web of Science ®Google Scholar
• Ihira K, Dong P, Xiong Y, et al. EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis. Oncotarget. 2017;8(8):13509–13520. doi:10.18632/oncotarget.1458628088786
   PubMedGoogle Scholar
• Smolle MA, Pichler M. The role of long non-coding RNAs in osteosarcoma. Non-coding RNA. 2018;4:1. doi:10.3390/ncrna4010007
   Google Scholar
• Lu Y, Zhao X, Liu Q, et al. lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/beta-catenin signaling. Nat Med. 2017;23(11):1331–1341. doi:10.1038/nm.442429035371
   PubMed Web of Science ®Google Scholar
• Huang PS, Chung IH, Lin YH, Lin TK, Chen WJ, Lin KH. The long non-coding RNA MIR503HG enhances proliferation of human ALK-negative anaplastic large-cell lymphoma. Int J Mol Sci. 2018;19:5.
   Web of Science ®Google Scholar
• Eide PW, Eilertsen IA, Sveen A, Lothe RA. Long noncoding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell-intrinsic properties. Int J Cancer. 2019;144(11):2843–2853. doi:10.1002/ijc.3199830447009
   PubMed Web of Science ®Google Scholar
• Dandan W, Jianliang C, Haiyan H, Hang M, Xuedong L. Long noncoding RNA MIR31HG is activated by SP1 and promotes cell migration and invasion by sponging miR-214 in NSCLC. Gene. 2019;692:223–230. doi:10.1016/j.gene.2018.12.07730659947
   PubMed Web of Science ®Google Scholar
• Wang S, Ke H, Zhang H, et al. LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci. Cell Death Dis. 2018;9(8):805. doi:10.1038/s41419-018-0869-230042378
   PubMed Web of Science ®Google Scholar